Rare mutations in human PHETA1 lead to Lowe oculocerebrorenal syndrome, which includes pathophysiology in seizures, mental retardation, and structural brain abnormalities (Kornfeld et al., 1975; Ates et al., 2020). The gene discussed is PHETA1; the disease is oculocerebrorenal syndrome.